Substance P, Arg(1)-Pro(2)-Trp(7),(9)-LeuNH(2)(11)- contains targeted residue modifications that alter backbone flexibility and aromatic interactions. The sequence allows evaluation of steric effects on folding and receptor recognition. Researchers analyze its conformational shifts and binding characteristics. Applications include motif analysis, peptide engineering, and structure-activity studies.
CAT No: R2470
CAS No:84676-91-5
Synonyms/Alias:84676-91-5;Aptlsp;Substance P, arg(1)-pro(2)-trp(7),(9)-leunh(2)(11)-;D-Arg(1)-D-pro(2)-D-trp-7,9-leunh(2)(11)-substance P;DTXSID20233656;Argininyl(1)-prolyl(2)-tryptophyl-7,9-leucinamide(11)-substance P;(D-Arg1,D-Pro2,D-Trp7.9,Leu11)-Substance P;Substance P, 1-D-arginine-2-D-proline-7-D-tryptophan-9-D-tryptophan-11-L-leucinamide-;(D-ARG1,D-PRO2,D-TRP7,9,LEU11)-SUBSTANCE P;MFCD00076804;DTXCID50156147;DA-69133;FA108556;(D-Arg1,D-Pro2,D-Trp7?9,Leu11)-Substance P;H-D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2; H-(dR)(dP)KPQQ(dW)F(dW)LL-NH2;
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.